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Abstract
Background: Several studies document disparities in access to care and quality of care for depression for African
Americans. Research suggests that patient attitudes and clinician communication behaviors may contribute to
these disparities. Evidence links patient-centered care to improvements in mental health outcomes; therefore,
quality improvement interventions that enhance this dimension of care are promising strategies to improve
treatment and outcomes of depression among African Americans. This paper describes the design of the BRIDGE
(Blacks Receiving Interventions for Depression and Gaining Empowerment) Study. The goal of the study is to
compare the effectiveness of two interventions for African-American patients with depression–a standard quality
improvement program and a patient-centered quality improvement program. The main hypothesis is that patients
in the patient-centered group will have a greater reduction in their depression symptoms, higher rates of
depression remission, and greater improvements in mental health functioning at six, twelve, and eighteen months
than patients in the standard group. The study also examines patient ratings of care and receipt of guideline-
concordant treatment for depression.
Methods/Design: A total of 36 primary care clinicians and 132 of their African-American patients with major
depressive disorder were recruited into a cluster randomized trial. The study uses intent-to-treat analyses to
compare the effectiveness of standard quality improvement interventions (academic detailing about depression
guidelines for clinicians and disease-oriented care management for their patients) and patient-centered quality
improvement interventions (communication skills training to enhance participatory decision-making for clinicians
and care management focused on explanatory models, socio-cultural barriers, and treatment preferences for their
patients) for improving outcomes over 12 months of follow-up.
Discussion: The BRIDGE Study includes clinicians and African-American patients in under-resourced community-
based practices who have not been well-represented in clinical trials to improve depression care. The patient-
centered and culturally targeted approach to depression care is a relatively new one that has not been tested in
most previous studies. The study will provide evidence about whether patient-centered accommodations improve
quality of care and outcomes to a greater extent than standard quality improvement strategies for African
Americans with depression.
Trial Registration: ClinicalTrials.gov NCT00243425
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In the United States, the majority of individuals with
mental disorders are untreated or poorly treated, and this
is particularly true for ethnic minorities [1,2]. Despite the
proven efficacy of pharmacotherapy and psychotherapy
for depression, several studies have found that African
Americans with depressive disorders receive lower qual-
ity of care [3-5]. African Americans are more likely to
seek mental health care in primary care settings [6],
where disparities in diagnosis [4,7] and appropriate phar-
macotherapy and psychotherapy referrals persist [3,4,8,9].
Disparities between African Americans and whites in the
adequacy of depression treatment are related to lower
rates of initiating treatment with antidepressant medica-
tions, and not to disparities in initiating counseling or
receiving adequate medications or counseling once
initiated[10,11]. Additionally, disparities in depression
care are not entirely explained by differences in educa-
tion, income, and health insurance coverage [5,12,13].
Physician knowledge, attitudes, and skills, patient-phy-
sician communication, as well as patient cultural beliefs,
attitudes, and preferences, are potential intervention tar-
gets to improve outcomes and reduce disparities in
depression care. Primary care physicians discuss depres-
sion at lower rates and engage in less rapport-building
with African-American patients [14]; this could partially
explain lower recognition and treatment rates among
African-American patients. Compared to white patients,
African-American patients express stronger preferences
for counseling [15] and spiritual approaches [16], and
more negative attitudes toward antidepressant medica-
tion [17,18], the most common form of treatment of
depression used by primary care physicians.
Although quality improvement (QI) strategies for
depression enhance appropriate care and improve clini-
cal outcomes among minorities, some of these interven-
tions are less effective among minorities than whites at
improving functional outcomes, and they do not elimi-
nate disparities in depression treatment and clinical out-
comes over 12 months [19,20]. The Institute of
Medicine includes patient-centeredness–’providing care
that is respectful of and responsive to individual patient
preferences, needs, and values, and ensuring that patient
values guide all clinical decisions’–as an important
dimension of healthcare quality [21]. Interventions that
focus on patient-centered communication have shown
improvements in patient adherence, patient satisfaction,
and mental health outcomes [22]. Additionally, interven-
tions that use cultural leveraging increase patients’
knowledge, decrease access barriers, and improve provi-
ders’ cultural competence [23]. However, with a few
exceptions [19,24], most QI strategies for depression tar-
get provider knowledge of treatment guidelines and
disease-oriented collaborative case management of
patients, rather than the quality of patient-clinician
communication or the cultural acceptability of treatment
approaches for patients [25-28]. Improving outcomes for
ethnic minority patients with depression beyond those
achieved in standard QI interventions may require inter-
ventions aimed at improving patient-clinician relation-
ships and making healthcare systems more responsive to
patients’ needs and preferences.
Methods
Study design and specific aims
Specific aim one
Recruit 30 primary care clinicians and 250 of their Afri-
can-American patients with major depressive disorder
(MDD) into the Patient-Centered Depression Care for
African Americans study. The study has an acronym,
‘BRIDGE’–Black Receiving Interventions for Depression
and Gaining Empowerment. BRIDGE is a cluster rando-
mized controlled trial with two experimental groups: a
standard state-of-the-art depression intervention based
on the chronic care model and a patient-centered inter-
vention that supplements standard interventions for
depression by tailoring them to individual patients’ sta-
ted concerns and incorporating patient-centered com-
munication skills and cultural sensitivity training for
clinicians (Figure 1).
Specific aim two
Compare the effectiveness of the patient-centered inter-
vention with the effectiveness of the standard interven-
tion by evaluating their impact on the following patient
outcomes at six and 12 months: depression symptom
reduction; depression remission; functional status
improvement; and receipt of guideline-concordant
treatment.
Specific aim three
Compare the effectiveness of the patient-centered inter-
vention with the effectiveness of the standard interven-
tion by evaluating their impact on the following
processes of care rated by patients at six and 12 months
of follow-up: satisfaction with the quality of technical
and interpersonal aspects of care in general; satisfaction
with depression care in particular, and patients’ and
clinicians’ attitudes regarding care of depression.
Interventions that target providers or patients alone
have been insufficient to improve quality of depression
care; therefore, it is important to test combined patient
and clinician interventions. When interventions that tar-
get clinicians are initiated while the effects of the out-
comes are measured at the patient level, a traditional
randomized trial design with one patient per provider
would offer optimal internal validity, but is often not
feasible because it requires randomizing a large number
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patients within each clinician cluster is theoretically pos-
sible and offers the added benefit of examining clinician
and patient intervention effects separately, it is logisti-
cally challenging, resource intensive, and presents the
relatively small possibility of cross contamination of
the patient intervention among patients within the same
clinician cluster. Therefore, for this study, the investiga-
tors chose a cluster design in which clinicians and their
patients were randomized as one unit.
We hypothesize that compared to patients in the stan-
dard intervention group, at follow-up, patients in the
patient-centered intervention group will decrease their
level of depressive symptoms, remit from depression,
improve their functional status, and receive guideline-
concordant treatment to a greater extent; give higher
ratings of partnership with providers, quality of depres-
sion care, and satisfaction; and report more positive atti-
tudes regarding treatment choices for depression.
Study populations and settings
The BRIDGE study occurs in urban primary care sites in
Baltimore, Maryland and Wilmington and Newark,
Delaware. Maryland primary care sites are affiliated with
Baltimore Medical System (one site), Baltimore Medical
Surgical Associates, an affiliate of Greater Baltimore
Medical Center (one site), Johns Hopkins Community
Physicians (five sites), and Sinai Hospital, a member of
MedStar Health (one site). Delaware primary care sites
include two federally-qualified community health cen-
ters–Henrietta Johnson Medical Center (one site) and
Westside Family Health (one site). These sites were cho-
sen because they are community-based, serve a patient
population that is at least 50% African American,
include patients with a range of socioeconomic back-
grounds, and are interested in improving care for their
African-American patients.
Recruitment strategies
Clinicians
Clinicians received an introductory letter that described
the study and was co-signed by the medical director of
their respective organization and the principal investiga-
tor. The letter outlined the goals of the study, gave a
general description of the interventions, and described
the responsibilities of clinicians caring for study patients.
The letter also informed clinicians they would receive
continuing medical education (CME) credits; an educa-
tional program about depression delivered to them in
their office by a primary care physician/psychiatrist
team; tailored, individualized feedback regarding their
interviewing skills (either during or at the end of the
study), and $200 paid to them or their organization.
Subsequently, the principal investigator explained the
study to prospective clinician participants at regular
Figure 1 BRIDGE study design.
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had. At the conclusion of the presentation, clinicians
were given a sign-up form that they could return imme-
diately, fax, or mail to the principal investigator’so f f i c e .
Research staff made follow-up phone calls or visits to
sites that had additional questions and to clinicians who
did not respond within two weeks of a site presentation.
Practice leaders facilitated communication with the clin-
icians and their staff.
Patients
On onsite recruitment days, participating clinics placed
signs in registration areas that asked, ‘Do you want to
improve your emotional health and possibly earn up to
$75?’ The signs also specified which clinicians were par-
ticipating in the study. During registration, patients were
given a card that informed them their clinician was par-
ticipating in a study to improve emotional health in
African Americans, and they might be approached by a
research assistant to ask if they were willing to partici-
pate. The patient could return the card to the reception-
ist if the patient was not African-American and/or did
not wish to be approached. Those who agreed to be
screened completed the procedures in a private area of
the clinic. The research assistant described the study
and obtained verbal consent to complete a 10-minute
depression screening interview in a private room.
Patients who were positive on the first-stage depression
screen completed full written study consent, and a
research assistant arranged for the patient’s medical visit
to be audio taped.
Patients who screened positive for depressive symp-
toms in clinical sites were called at home within two
weeks of their onsite screening to complete the second-
stage screen (to determine whether they had a diagnosis
of MDD by the Composite International Diagnostic
Interview, or CIDI) with a 40-minute telephone baseline
interview [29,30]. If they met diagnostic criteria, they
were randomized according to their clinician’si n t e r v e n -
tion assignment and told to expect a phone call from a
depression care manager within a few days; interviewers
also obtained respondents’ consent to be called for 30-
minute follow-up interviews at 6, 12, and 18 months
from the baseline interview.
Two other recruitment strategies supplemented the
onsite approach. For these patient recruitment
approaches, we obtained a waiver of HIPAA privacy
authorization from the Johns Hopkins IRB and entered
into agreements with the participating health plans to
allow data sharing. The second recruitment approach
was to have clinical managers at participating primary
care sites help identify potential African-American study
subjects using administrative and scheduling data. Field
research staff then did onsite recruitment and screening
at clinics where African-American patients were already
scheduled to see a participating provider. The third
patient recruitment approach was developed to meet
requests from many participating clinicians that the
study include some of their patients with known depres-
sion. Clinicians were asked to nominate 20 of their
known African-American patient cases with MDD for
possible inclusion in the study. Clinicians recommended
patients with a broad spectrum of depression symptoms
and in various stages of care. We sought and obtained
IRB approval for clinicians to give research assistants
patient contact information (i.e., name, address, phone
number, and medical record number) for the purpose of
preparing a letter that would be signed by the patient’s
clinician. Information packets containing the clinician’s
signed letter detailing the study goals and objectives and
a prepaid study postcard that offered patients an option
to refuse participation were sent to potential partici-
pants. Upon receipt of the letter, patients either called
the study office, or, if no refusal postcard was received
within two weeks of the mailing, they were called by
study staff. In either case, during the telephone call
patients were told about the study, asked questions to
confirm eligibility, and asked if they would be willing to
speak further about the study with a member of the
study staff when they arrived at their next appointment.
If they agreed, a field research assistant met the patient
at the clinic prior to their next appointment. The
research assistant administered the brief screening ques-
tionnaire, and the recruitment process proceeded as
described above.
Eligibility criteria
Clinicians recruited for the BRIDGE study were general
internists, family physicians, and nurse practitioners who
saw patients at least 20 hours per week at one of the
participating study sites. The clinicians were recruited
without regard to race, gender, or age. Patients had to
be between the ages of 18 and 75 years and report their
race or ethnicity as African American; they had to be
positive on a screener for major depressive and dysthy-
mic disorder from the CIDI [30], which identified indivi-
duals who reported two weeks or more during the last
year and one week or more during the past month
when they felt sad, empty, depressed, or lost interest in
things they normally enjoyed. The screener was self-
administered with assistance as needed at the time of
the recruitment visit. In addition, screen-positive
patients had to meet criteria for one-year major depres-
sion on a subsequent structured interview [30], defined
as: meeting DSM-IV criteria for MDD in the past year
[31]and having symptoms present for at least one week
i nt h ep a s tm o n t h ,t ob ec o n s i d e r e de l i g i b l ef o rt h e
study. Patients were excluded if they had an acute life-
threatening condition or cognitive impairment that pre-
vented them from completing the screener; indicated
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ongoing basis; had no access to a telephone; were cur-
rently pregnant, breastfeeding, or less than three months
postpartum; screened positive for current bereavement,
lifetime mania, or current alcohol or drug abuse; did not
speak English; were currently receiving specialty mental
health care; or reported immigrating to the United
States within the preceding five years.
Randomization
Randomization was stratified by study site and conducted
at the clinician level with patients sequentially selected
within each randomized clinician (10 patients from each
clinician). Within each study site (stratum), a randomiza-
tion schedule was generated through computer by the
study statistician using the Moses and Oakford algorithm
[32]with the block sizes of two or four randomly created
in a four to one ratio. Informed consent and baseline data
collection from clinicians (background questionnaire and
videotaped interview with the standardized patient) were
completed before participating clinicians were randomly
assigned (using a blind and secure allocation by computer)
to either the standard or the patient-centered intervention.
At the screening visit, patients of enrolled clinicians pro-
vided oral consent to complete the screening question-
naire. Once eligibility was confirmed, written consent and
screening visit data were collected. Additionally, study
staff obtained permission from eligible patients to contact
them several times over the next 12 months. Patients were
then assigned to the standard or patient-centered inter-
vention according to their clinicians’ randomization status.
The patient recruiters were blinded to the clinicians’ ran-
domization assignment during recruitment, and the
patients did not know their assigned treatment status until
after enrollment. Due to the behavioral nature of the inter-
ventions, blinding or masking of study participants, inves-
tigators, and depression care managers was not possible.
However, interviewers who collected baseline and follow-
up data from patients at six and 12 months were masked
to clinician and patient intervention assignment.
Interventions
Clinician interventions
The clinician interventions were developed on a model
previously shown to improve treatment knowledge for
primary care clinicians [33,34]. Over the course of the
study’s 12-month clinician intervention period, clinicians
in both intervention groups received two academic
detailing visits for CME credit on the clinical manage-
ment of depression from a team consisting of a primary
care physician and a consultation-liaison psychiatrist.
The visits were delivered within a two-month period, on
average, for each clinician and focused on the latest
advances in depression diagnosis and assessment (visit
one) as well as treatment and referral (visit two), using
the MacArthur Initiative on Depression and Primary
Care Toolkit for clinicians [35]. The team visited clini-
cians individually or as a group according to the collec-
tive preference of clinicians at each site. In addition to
approximately two hours of formal training, all clinicians
received a monthly newsletter with study updates and
summaries of recent journal articles related to depres-
sion. Each clinician who faced difficulty with patient
diagnosis, motivation to initiate treatment, adherence to
treatment, or response to treatment was invited to con-
tact his or her consultation-liaison psychiatrist. Consul-
tative services via monthly case conferences and
collaborative patient visits were offered by the study psy-
chiatrists; however, primary care clinicians chose to con-
tact the consultants by telephone instead.
In contrast to the more didactic format used in the
standard clinician intervention, the primary care physi-
cian/psychiatrist team that delivered academic detailing
to clinicians in the patient-centered intervention guided
each clinician through his or her personal interactive
communication skills training program in a one-on-one
or small group format with other clinicians in the prac-
tice who were also assigned to this intervention. The
program featured a CD-ROM containing the clinician’s
interview with a simulated patient at baseline, fully-ana-
lyzed using the Roter Interaction Analysis System
(RIAS) [36,37]. This sophisticated coding software gen-
erated tabular and graphic analyses of the verbal com-
ponents of the interview (e.g., functional categories of
communication and proficiencies useful in improving
patient involvement in decision-making about depres-
sion treatment). Clinicians were also presented with the
overall ratio of clinician to patient talk as a measure of
verbal dominance [38]. The RIAS is based on a four-
function model of medical interviewing that includes
data-gathering, rapport-building, patient education and
counseling, and facilitation and patient activation [39].
There were also targeted proficiencies related to depres-
sion included in the training program: recognizing
depression; evaluating patients for associated conditions
and suicidal ideation; assessing functioning and coping
strategies, knowledge and beliefs about depression, and
treatment preferences and concerns; and eliciting a
commitment to the therapeutic plan. After viewing the
analysis of communication by category, the software
enabled clinicians to efficiently review examples of each
function and proficiency within the interview. The
CD-ROM also featured a video-glossary of simulated
interviews illustrating the communication skills corre-
sponding to each category.Ac o m p a n i o nw o r k b o o k
introduced clinicians to the RIAS and guided them
through case-based exercises for skill practice.
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The standard and patient-centered patient interventions
were both designed to incorporate state-of-the-art strate-
gies that have been proven to enhance the quality of care
for depression in primary care settings. Each intervention
involved extensive one-on-one follow-up with a Depres-
sion Case Manager (DCM) to assess patients’ depression
status and to encourage adherence to recommended
treatments and exposure to educational materials. Both
DCMs were social workers with clinical experience; the
standard DCM was a Caucasian woman, and the patient-
centered DCM was an African-American woman.
The format and schedule for DCM contact were stan-
dardized across both interventions. Enrolled patients
were contacted by their DCM within a week of the
baseline telephone interview to schedule a 45-minute
telephone conversation. Follow-up calls at one week,
two weeks, and four to six weeks assessed each patient’s
depression level measured by the Patient Health Ques-
tionnaire (PHQ-9) score [40]. Symptomatic patients in
the acute phase received weekly calls, while asympto-
matic patients in the continuation and maintenance
phases were called every eight and 12 weeks, respec-
tively. Each DCM was also available to her patients by
telephone as needed throughout the duration of the 12-
month intervention.
The common goals of the standard and patient-cen-
tered DCMs were to provide needs assessment (five
core areas for the standard DCM, 11 core areas for the
patient-centered DCM), education, and activation mes-
sages to patients (Table 1). In addition to core areas, the
needs assessment touched on active coping strategies,
social stressors, and social support. To increase the effi-
ciency and effectiveness of depression care, during
every follow-up call each DCM monitored symptoms,
functional status, and general health of her patients. In
addition, each DCM reviewed the psychotherapy, medi-
cation, and/or alternative treatment plan developed by
the patient and his or her primary care clinician. A
report of relevant information was prepared for the
patient, primary care clinician, and/or mental health
specialist after each contact.
In contrast to the standard DCM, the patient-centered
DCM conducted a more comprehensive needs assess-
ment that explored the meaning of illness from the
patient’s perspective [41], his or her use of spirituality as
an active coping strategy, and social stressors such as
racial discrimination, neighborhood safety, financial bur-
dens, stigma, health literacy, and relationships with
health professionals. She then used this patient-specific
information to guide her engagement and supportive
counseling of the patient and provided interested
patients with the names and contact information for
culturally-sensitive psychotherapists.
Patients in both interventions were asked by their
DCM to try at least two educational materials, which
were mailed after the initial telephone conversation. The
educational materials include brochures (2004 versions),
books, and DVDs/videotapes. The patient-centered
intervention materials were culturally targeted and
included a study calendar and a nondenominational
depression prayer card for patients who described them-
selves as spiritual. Materials provided in each interven-
tion are shown in Table 2[42-46]. The Black and Blue
video/DVD [47] was innovative in featuring actual Afri-
can-American patients rather than actors, targeting bar-
riers to treatment for African Americans identified in
previous research, and incorporating the viewpoints of
African-American primary care physicians, mental
health professionals, and clergy. The BRIDGE study
calendar offered additional reinforcement on topics such
as depression in the African-American community, sub-
stance abuse, safe and effective therapy and medication,
spirituality, self-help, and suicide prevention.
Data collection at baseline and over follow-up
In addition to the main outcome and process measures,
baseline data were collected to describe the characteris-
tics of study subjects and compare these characteristics
between the intervention groups assigned by randomiza-
tion. While the intervention status is the main predictor
variable, other factors known to be predictors of depres-
sion (e.g., social support) and factors that might explain
why the intervention did or did not work (e.g., clinician
and patient attitudes regarding treatment) were col-
lected. In general, we selected instruments that are brief,
have been used successfully in primary care settings,
Table 1 Features of the BRIDGE study patient
intervention
Data collected/delivered Standard
intervention
Patient-centered
intervention
Needs assessment (five core
assessment areas)
X
Patient-centered needs assessment
1
(11 core assessment areas)[41]
X
Education and Activation X X
Social support/informal counseling X X
Standard education materials X
Culturally targeted education
materials
X
Black mental health alliance resource
list
X
Cultural information packet for MH
Providers
X
1More in-depth individualized questioning (using Kleinman’s explanatory
model approach [41]) about symptoms, functional status, social support,
treatment preferences compared to the standard needs assessment.
Additional assessment questionswere about literacy and language, spirituality,
financial concerns, and clinician relationship.
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African Americans. We also collected detailed data on
racial identity and other attitudes, beliefs, and experi-
ences that might identify intra-ethnic group differences
and help determine the study’s external validity. We
conducted telephone interviews to measure patients’
depression status, attitudes regarding treatment, use of
health services and experiences of care, and reactions to
the interventions at six and 12 months of follow-up.
Table 3 shows the variables collected from individual
clinicians at baseline (pre-intervention), immediately
after their in-person intervention contacts (post-inter-
vention), and at the end of the study. Table 4 shows
socio-demographic and behavioral variables, clinical
measures, and health service utilization patterns col-
lected from patients at baseline and over follow-up.
One modification to the original study protocol was
made shortly after the 12-month follow-up was complete.
Because the pattern of improvement differed between
intervention groups at six months and 12 months of fol-
low-up, a decision was made to extend follow-up to one
additional interview at 18 months, and IRB approval was
obtained to re-contact study patients. However, because
outcomes assessors at 18 months were not blinded to
intervention assignment, depression status at 12 months
remains the study’s primary outcome.
Main outcome measures and statistical analysis plan
Randomly assigned intervention group (standard versus
patient-centered) is the main independent variable for
intent-to-treat (ITT) analyses. Clinic site is a
stratification variable for randomization and is expected
to be balanced across intervention groups by design.
T h ep r i m a r yo u t c o m ev a r i a b l ei sc h a n g ei nd e p r e s s i o n
symptom severity, upon which we base the sample size
evaluation to ensure proper statistical power. Descriptive
statistics will be used to describe patient and clinician
characteristics at baseline. The comparability of clinician
characteristics between intervention groups will be
determined for sociodemographic data as well as pre-
intervention measures of training, attitudes,
management of depression, and communication style.
Comparability of patient characteristics between
intervention groups will be assessed with regard to pre-
intervention sociodemographics, depression level, health
status measures, and other key variables. Variables
found to be unbalanced between intervention groups
will be adjusted for in all ITT analyses. Adherence to
Table 2 Patient education materials
Standard
intervention
Patient-centered
intervention
Communication material
Book
How to Heal Depression [42] X
Chicken Soup for the African
American Soul [43]
X
Print media
Depression [44] X
Depression and African
Americans [45]
X
Prayer Card X
Real Men, Real Depression [44] X
Men and Depression
1 [44] X
Visual media
Coping with Symptoms of
Depression, DVD or Video [46]
X
Black and Blue, DVD or Video
[47]
X
Calendar X
1Distributed to men only
Table 3 Schedule of data collected from primary care
clinicians in the BRIDGE study
Overall data collection Pre
intervention
Post
intervention
Demographics (age, gender, race,
ethnicity, place of birth, residency training,
board certification status, practice
experience)
X
Specialty (internal medicine or family
medicine)
X
Previous communication skills CME
training
XX
Previous mental health CME training X X
Readiness to change behavior re:
management of depression
X
Knowledge, attitudes, self-efficacy re:
managing depression
X
Attitudes about race
1 XX
Self-reported communication and PDM
style
X
Job stress and satisfaction X
Self-efficacy in managing adherence
problems, depression, and patients from
socially and culturally diverse backgrounds
XX
Visit level data collection
Videotape with simulated patient X
Audiotapes with 5 to 10 depressed
patients
X
Visit-specific satisfaction with each patient X
Perceptions of patients’ social and
behavioral characteristics
X
Use/process evaluation of CD-ROM/
workbook
2
X
Rating of intervention effectiveness X
1Explicit attitudes measured at baseline before enrollment visit; implicit
attitudes measured only at end of study using the Implicit Association Test
(IAT).
2Patient-centered intervention providers only
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will be considered as a covariate in subsidiary, on-treat-
ment analyses.
T h ed a t ao no u t c o m ev a r i a b l e sf a l li n t ot w ob r o a d
categories: continuous variables, such as depressive
symptom score (CES-D) [48] and functional status
scores (MOS SF-12) [49], and dichotomous variables,
such as depression remission status and receipt of
guideline-concordant treatment. The primary ITT ana-
lyses are designed as regression modeling using
patients as the unit of analysis, with each regression
model structured to have a parameter designated for
each visit where the outcome of the model was sched-
uled to be assessed, separately for each intervention
group, so that the mean model is fully saturated for
the intervention by visit parametrization. This parame-
trization allows estimation of mean differences
observed within each intervention group betweeen
baseline and a given follow-up visit for a continuous
outcome, and odds ratios of having the outcome event
at a given follow-up versus the baseline visit within
each intervention group for a binary outcome, after
adjusting for other covariates in the model. The evalu-
tion of patient-centered intervention effects will be
c o n d u c t e db yt e s t i n gt h es i g n i f i c a n c eo fd i f f e r e n c eo f
the adjusted mean differences, or the ratio of adjusted
odds ratios, of a given follow-up versus the baseline
visit between the intervention groups. The primary
testing contrast is the baseline to 12-month change in
outcomes between intervention groups; the models can
easily accommodate additional data obtained by
extending the follow-up to 18 months.
Site and clinician characteristics are included as cov-
ariates in all regression models to account for potential
patient outcome clustering within clinical sites and/or
clinicians. To account for longitudinal correlations
between outcome assessed over time within patients,
mixed effects modeling appraches with unstructured
correlation matrix are used whenever possible. Robust
estimation is used for statistical inferences. The likeli-
hood approach underlying the proposed mixed effects
modeling would produce valid statistical inferences with
missing data if the missing mechanism is Missing at
Random (MAR) and the proposed mean and correlation
models are correct. We thus anchor our ITT analyses
on mean models with fully saturated visit by interven-
tion parametrization plus all the covariates as necessary,
paired with an unstructured correlation model to
develop valid statistical inferences under MAR. We then
conduct sensitivity analyses through multiple imputation
under plausible missing scenarios that are non-MAR to
examine the robustness of our inferences under such
situations.
Sample size considerations
One of the major hypotheses to be tested is that
improvements in CES-D scores for depressed patients in
the patient-centered intervention group will be greater
than those in the standard intervention group. Previous
studies of treatment of depression in primary care using
similar interventions (excluding the patient-centered and
cultural adaptations) have shown remission and symp-
tom improvement differences between intervention and
usual care groups of 20 to 30% [19,20]. Our resources
and available recruitment pools allowed us to aim for 15
Table 4 Schedule of variables collected from patients in the BRIDGE study
Measurement/collection method Enrollment
visit
6
months
12
months
18
months
Questionnaires
Sociodemographics XX X
Age, sex, race/ethnicity, education, income, employment
1, health insurance
1, financial stress
¶
Attitudes, beliefs, and other behavioral measures X X X X
Trust in health professionals, preferred role in decision-making, depression treatment preferences,
spirituality, respect, perceived involvement in care
2, racial identity, social support, life events
Health Status X XXX
Physical and mental, measured by MOS-SF12, CIDI
3 &ES-D, psychiatric co-morbidity
4, disability days
Healthcare Utilization X XXX
Mental healthcare utilization (receipt of antidepressant medication and/or counseling) General
healthcare utilization (emergency room visits and hospitalizations)
Healthcare Process X XXX
PDM with providers, visit-specific and overall satisfaction, satisfaction with case manager
5, ratings of
depression care management and intervention materials
6
Audiotapes (patient-provider communication)
7 X
CIDI = Composite International Diagnostic Interview, Depression Scale, CES-D = Center for Epidemiologic Studies Depression Scale, PDM = participatory decision
making;
1measured at 12 and 18 months;
2measured only at 18 months;
3not measured at six months;
4Substance abuse, panic attacks, anxiety, and traumatic
events;
5measured only at six and 12 months;
6measured only at 12 months only;
7collected at enrollment visit and after primary care provider intervention.
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Page 8 of 15clinicians and 125 patients per group, with an average
number of 8.3 patients per physician (cluster). By
assuming a within-cluster or intra-class correlation of
0.1 [50] and 15% dropouts by the end of 12 months fol-
low-up (reflected using the variance inflation factor), a
correlation between the baseline and 12 month CES-D
score of 0.5, a mean CES-D score of 30 points at base-
line for both intervention groups, 25% score reduction
(i.e., 7.5 points) by 12 months in the standard interven-
tion group, and the common cross-sectional SD for
CES-D of 10 points for both intervention groups at both
visits, we would have 80% statistical power to detect a
between-group difference of 3.6 points or more in
improvement in mean CES-D score at one year using a
two-sided test with Type I error of 0.05. That is, if we
expect to see a 7.5 point improvement in mean CES-D
score for the standard intervention group after one year,
then we would have 80% power to detect a 11.1 points
or greater improvement in mean CES-D score for the
patient-centered intervention group after one year.
Ethics and Consent
The trial received approval from the Johns Hopkins
and MedStar Health Institutional Review Boards.
Informed written consent was obtained from all partici-
pating clinicians and patients. Subjects were free to with-
draw from the study at any time, to refuse to answer any
question, and to either stop audiotaping or to have audio-
tapes of any visit dropped from the study. None of the
patient information was released to their clinician, health
care organization, or any other party without the patients’
permission. Phone contacts to locate the study subject
did not suggest the content of the study. All study data
were stored in locked file cabinets at Johns Hopkins and
not the clinical sites. Personal identifiers were removed
as soon as possible. Audiotape data were transferred onto
CD-ROMs for coding purposes, and stored in locked files
after identifiers were removed. A code key is kept in a
separate location restricted to the principal investigator
and project director. Each clinician received an incentive
of $200 paid to them individually or to their organization
and each patient received $25 for completing each
interview.
Baseline characteristics of study sample
Baseline characteristics of the clinicians
Clinicians were enrolled between June 2004 and March
2006. We contacted 108 clinicians, of whom 72 were
excluded; nine clinicians did not respond despite several
phone calls, faxes, and emails from the study, and 63
clinicians refused to participate, citing lack of time or
interest. Thirty-six clinicians were randomized to either
the patient-centered intervention (n = 15) or the stan-
dard QI intervention (n = 21); one of these clinicians
left the clinical site before baseline data collection and
intervention delivery; eight clinicians were unable to
contribute patients to the study (three left the site prior
to patient recruitment; one went on maternity leave,
and three were determined to have an inadequate
sample of potentially eligible patients in their panel).
(Figure 2) Characteristics of the 36 primary care clini-
cians recruited to the study are shown in Table 5. They
were mostly general internists (58%) with a mean age of
42.4 years and mean practice experience of 6.9 years.
Sixty-one percent were women, and they were ethnically
diverse (28% African American, 17% Asian, and 47%
White).
Baseline characteristics of patients
Research assistants approached 1,486 patients for elig-
ibility in waiting rooms between October 2005 and
August 2006; 613 refused to complete in-person screen-
ing and 642 were determined to be ineligible by the
first-stage screener (e.g. 457 were not depressed, 68
were positive for alcohol or drug abuse by the CAGE
AID [51,52], and 46 were currently seeing a mental
health specialist). Of the 231 patients eligible for the
second-stage screen, conducted by telephone, 35 refused
to complete it when called, 22 were unable to be
reached to confirm their eligibility, and 42 were categor-
ized as ineligible by the second-stage screen (CIDI).
(Figure 3) Table 6 shows baseline characteristics of the
132 patients enrolled in the study. These patients are
46.4 years on average; 80% are women and 100% are
African-American (4% also report being of Hispanic eth-
nicity). Forty-nine percent are high school graduates.
The average annual household income is $41,393; how-
ever, 28% find it very difficult to pay their monthly bills.
Fifty-eight percent are employed, and 89% have health
insurance. The mean scores on the CES-D, MCS-12,
and PCS-12 at baseline are 29.84, 36.18, and 42.12,
respectively. Fifty-six percent of the sample reported
having to take at least one disability day in the preced-
ing two weeks.
Discussion
Despite the proven efficacy of pharmacotherapy and
psychotherapy for treatment of depression, many
depressed primary care patients still do not receive ade-
quate treatment. Moreover, African Americans and
other ethnic minorities have lower rates of guideline-
concordant treatment for depression than whites. Stu-
dies have identified patient-clinician communication and
patient cultural beliefs, attitudes, and preferences as
potential targets for interventions to improve outcomes
and reduce disparities in care. Current state-of-the-art
interventions still struggle to achieve one-year remission
rates over 65% for patients with major depression [53].
While these interventions result in clinical improvement
for ethnic minority patients, disparities in receipt of
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Page 9 of 15guideline-concordant care and functional outcomes are
not eliminated [19].
This study compares the effectiveness of a patient-
centered, culturally targeted adaptation with the
standard conceptually-based QI intervention that was
proven to be helpful for improving care for depression.
The adapted intervention incorporates several successful
features of previous QI interventions while also introdu-
cing novel elements. Both interventions use multifaceted
approaches that include educational and epidemiological
strategies to target intrinsic motivation and rational
decision-making among health professionals [54]. The
patient-centered adaptation aims to enhance clinicians’
participatory decision-making skills and uses marketing
strategies to adjust educational products and care man-
agement services to the needs of African Americans
[54].
Limitations of the study should be discussed. The
cluster design presents unique challenges with regard to
comparability of groups (at the cluster and individual
Figure 2 BRIDGE study CONSORT flowchart for clinicians.
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ITT principles, empty clusters, and participant switches
from one cluster to another [55]. Several strategies have
been recommended to overcome recruitment challenges:
monitoring cluster guardian (e.g., practice leader) adher-
ence to the study protocol before randomization of the
cluster; including at least one patient participant before
randomizing a cluster; and using recruiters who are
blinded to participant allocation status. In this study,
there was loss to follow-up among randomized clini-
cians before patient recruitment, which led to empty
clusters (e.g., clinicians who did not contribute patients
to the study) and failure to reach the recruitment
target among patients, which may compromise the
study’s statistical power to detect differences in the pri-
mary outcome. Due to the staff resources available for
recruitment and time frame needed for delivery of the
clinician interventions, it was not feasible to delay ran-
domization of clinicians until the first patient in each
cluster was recruited. However, recruiters in this study
were blinded to the allocation status of each cluster and
its patients. With regard to analysis challenges, empty
clusters and patients who switch from one cluster to
another may lead to violation of the ITT principle.
Recommendations include taking into account both
clusters and individuals that withdraw or are lost to fol-
low-up by using ad hoc missing data methods; keeping
clusters as they were randomized, and using adjustment
or propensity-score methods to deal with potential
imbalances in both cluster and individual characteristics.
In addition to these strategies, we will conduct sensitiv-
ity analyses to examine the potential impact of deviation
from assumptions underlying such analytic approaches
on the robustness of the study findings. Another design
constraint is the limited ability to identify which aspects
of the multi component interventions are most effective;
we intend to conduct post-hoc analyses to determine
whether the number of intervention contacts, use of
intervention materials, and rating of intervention effec-
tiveness by clinicians and patients are related to study
outcomes.
Limitations of the interventions include the lack of
booster exposures for clinicians and the reliance on tele-
phone contacts and limited focus on enhancing access
to psychotherapy for patients. These limitations were
dictated by concerns about interference of the clinician
interventions with clinical care and productivity; lack of
office space for interventionists; and heterogeneous
access to mental health specialists among patients with
different health insurance coverage. Data collection and
follow-up limitations include the reliance on self-report
measures of process and health outcomes and relatively
short follow-up time frame for assessment of functional
outcomes from patients.
Still, the BRIDGE study addresses several limitations
of previous studies. It includes under-resourced commu-
nity-based practices and clinicians and African-Ameri-
can patients who have not been well-represented in
previous clinical trials to improve depression care.
Moreover, the patient-centered and culturally tailored
approach to depression care is a relatively new one that
has not been tested in most previous studies. The inves-
tigators found establishing strong relationships and
aligning priorities with practice leadership early in the
design of the study and throughout its implementation
enhanced the success of recruitment at particular sites.
Additionally, drawing on the strengths of site-specific
Table 5 BRIDGE Study: Demographic and baseline
characteristics for 36 primary care clinicians
Characteristic No. of
PCPs (%)
Mean (standard
deviation)
Age, years 42.4 (9.7)
Women 22 (61)
Ethnicity
African American 10 (28)
Asian 6 (17)
White 17 (47)
Other 3 (8)
Experience at current practice, years 6.9 (7.0)
Internal medicine 21 (58)
Board certified 27 (75)
CME in the past three years, hours
Communication 6.2 (11.7)
Depression 5.0 (7.79)
Diversity 5.7 (20.12)
Definitely:
Need to change way evaluate and
manage MDD
3 (8)
Make an effort to change way
evaluate and manage MDD
7 (19)
Likelihood of first-line treatment
Very likely:
Assess but not treatment 1 (3)
Prescribe medication 18 (50)
Counsel 6 (17)
Refer to mental health specialist 14 (39)
Very confident caring for:
Socially disadvantaged 16 (44)
Minority patients 19 (53)
Very skilled in:
Diagnosing major depression 9 (25)
Managing simple antidepressant
therapy (one med)
10 (29)
Providing emotional support 5 (15)
Following those in remission every
six months
9 (25)
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Page 12 of 15administrative staff and electronic medical resources,
when available, and adapting to the needs of clinicians
and practices increased the efficiency and effectiveness
of patient recruitment and acceptability and delivery of
the interventions. The BRIDGE study will provide
knowledge about how to recruit and enroll clinicians
and patients into community-based participatory
research programs; how to change clinicians’ behaviors
with regard to depression care in actual practice; and
how to improve acceptability of treatments, quality of
care, and depression outcomes for African Americans
and other ethnic minorities with depression.
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